Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 3 | $108,080,991 |
| Sells | 31 | $5,461,501 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 04 Oct 2024 18:01 | ZNTL | Zentalis Pharmaceuticals Inc | VULTAGGIO VINCENT | Principal Accounting Officer | 04 Oct 2024 | Sale | 1,603 | 3.18 | 5,098 | D |
| 31 May 2024 18:27 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President, Interim CFO | 31 May 2024 | Sale | 9,597 | 11.98 | 114,972 | D |
| 09 May 2024 19:46 | ZNTL | Zentalis Pharmaceuticals Inc | HAUSMAN DIANA | Chief Medical Officer | 09 May 2024 | Sale | 3,356 | 12.62 | 42,353 | D |
| 12 Feb 2024 20:22 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 12 Feb 2024 | Sale | 2,573 | 11.44 | 29,435 | D |
| 12 Feb 2024 20:21 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 12 Feb 2024 | Sale | 1,173 | 11.44 | 13,419 | D |
| 05 Feb 2024 19:15 | ZNTL | Zentalis Pharmaceuticals Inc | LACKNER MARK | Chief Scientific Officer | 02 Feb 2024 | Sale | 1,585 | 11.54 | 18,291 | D |
| 05 Feb 2024 19:14 | ZNTL | Zentalis Pharmaceuticals Inc | PAUL ANDREA | Chief Legal Officer | 02 Feb 2024 | Sale | 3,310 | 11.54 | 38,197 | D |
| 05 Feb 2024 19:13 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 02 Feb 2024 | Sale | 11,552 | 11.54 | 133,310 | D |
| 05 Feb 2024 19:12 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 02 Feb 2024 | Sale | 8,669 | 11.54 | 100,040 | D |
| 13 Nov 2023 17:24 | ZNTL | Zentalis Pharmaceuticals Inc | JOHNSON DAVID MICHAEL | Director | 10 Nov 2023 | Purchase | 17,000 | 9.879 | 167,943 | D |
| 13 Nov 2023 17:24 | ZNTL | Zentalis Pharmaceuticals Inc | BLACKWELL KIMBERLY | Chief Executive Officer | 13 Nov 2023 | Purchase | 5,000 | 10.2896 | 51,448 | D |
| 06 Oct 2023 19:19 | ZNTL | Zentalis Pharmaceuticals Inc | BROWNSTEIN CARRIE | Chief Medical Officer | 04 Oct 2023 | Sale | 8,906 | 19.4265 | 173,012 | D |
| 06 Oct 2023 19:19 | ZNTL | Zentalis Pharmaceuticals Inc | BROWNSTEIN CARRIE | Chief Medical Officer | 04 Oct 2023 | Sale | 1,722 | 19.9102 | 34,285 | D |
| 06 Oct 2023 19:19 | ZNTL | Zentalis Pharmaceuticals Inc | BUNKER KEVIN D. | Chief Scientific Officer | 04 Oct 2023 | Sale | 983 | 19.9102 | 19,572 | D |
| 06 Oct 2023 19:19 | ZNTL | Zentalis Pharmaceuticals Inc | BUNKER KEVIN D. | Chief Scientific Officer | 04 Oct 2023 | Sale | 5,085 | 19.4265 | 98,784 | D |
| 06 Oct 2023 19:18 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 04 Oct 2023 | Sale | 888 | 19.9102 | 17,680 | D |
| 06 Oct 2023 19:18 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 04 Oct 2023 | Sale | 4,594 | 19.4265 | 89,245 | D |
| 13 Sep 2023 16:11 | ZNTL | Zentalis Pharmaceuticals Inc | SKVARKA JAN | Director | 11 Sep 2023 | Sale | 5,000 | 25.0475 | 125,238 | D |
| 20 Jun 2023 16:30 | ZNTL | Zentalis Pharmaceuticals Inc | MATRIX CAPITAL MANAGEMENT COMPANY, LP | 10% | 20 Jun 2023 | Purchase | 4,760,000 | 22.66 | 107,861,600 | I |
| 31 May 2023 21:10 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 31 May 2023 | Sale | 18,526 | 26.2079 | 485,528 | D |
| 31 May 2023 21:10 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 31 May 2023 | Sale | 9,242 | 26.3989 | 243,979 | D |
| 31 May 2023 21:09 | ZNTL | Zentalis Pharmaceuticals Inc | BUNKER KEVIN D. | Chief Scientific Officer | 26 May 2023 | Sale | 80,000 | 30.0156 | 2,401,248 | I |
| 14 Feb 2023 19:10 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 14 Feb 2023 | Sale | 5,227 | 19.9753 | 104,411 | D |
| 14 Feb 2023 19:10 | ZNTL | Zentalis Pharmaceuticals Inc | EPPERLY MELISSA B, | Chief Financial Officer | 13 Feb 2023 | Sale | 2,624 | 20.4244 | 53,594 | D |
| 14 Feb 2023 19:09 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 14 Feb 2023 | Sale | 8,501 | 19.9631 | 169,706 | D |
| 14 Feb 2023 19:09 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 13 Feb 2023 | Sale | 3,332 | 20.4244 | 68,054 | D |
| 14 Feb 2023 19:07 | ZNTL | Zentalis Pharmaceuticals Inc | BUNKER KEVIN D. | Chief Scientific Officer | 14 Feb 2023 | Sale | 6,500 | 19.9805 | 129,873 | D |
| 14 Feb 2023 19:07 | ZNTL | Zentalis Pharmaceuticals Inc | BUNKER KEVIN D. | Chief Scientific Officer | 13 Feb 2023 | Sale | 3,807 | 20.4244 | 77,756 | D |
| 06 Feb 2023 19:36 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 06 Feb 2023 | Sale | 572 | 23.0351 | 13,176 | D |
| 06 Feb 2023 19:36 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 06 Feb 2023 | Sale | 9,428 | 22.2213 | 209,502 | D |
| 18 Jan 2023 17:15 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 17 Jan 2023 | Sale | 500 | 24.8672 | 12,434 | D |
| 18 Jan 2023 17:15 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 17 Jan 2023 | Sale | 9,500 | 24.1138 | 229,081 | D |
| 05 Jan 2023 19:16 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 05 Jan 2023 | Sale | 300 | 21.4567 | 6,437 | D |
| 05 Jan 2023 19:16 | ZNTL | Zentalis Pharmaceuticals Inc | GALLAGHER CAM | President | 05 Jan 2023 | Sale | 9,700 | 21.0094 | 203,791 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)